| 药品名称 | ILOTYCIN | | 申请号 | 050368 | 产品号 | 001 | | 活性成分 | ERYTHROMYCIN | 市场状态 | 停止上市 | | 剂型或给药途径 | OINTMENT;OPHTHALMIC | 规格 | 0.5% | | 治疗等效代码 | | 参比药物 | 否 | | 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | DISTA PRODUCTS CO DIV ELI LILLY AND CO
| | 化学类型 | | 审评分类 | |
|
|
| 与本品相关的专利信息（来自橙皮书Orange Book） | | 专利号 | 专利过期日 | 是否化合物专利 | 是否产品专利 | 专利用途代码 | 专利下载 | | 无 | | 历史专利信息 | | 无 |
|
| 与本品相关的市场独占权保护信息 | | 独占权代码 | 失效日期 | | 无 | | 历史市场独占权保护信息 | | 无 |
|
| 与药品注册相关的信息 | | 申请号 | 修订号 | 审批结论 | 公开文档类型 | 文档创建时间 | 获取文档 | | 无 |
|
| 药品注册审批历史信息 | | 申请号 | 修订号 | 审批结论 | 审批日期 | 审批内容 | | 050368 | 041 | AP | 1988/07/13 | Manufacturing Change or Addition | | 050368 | 040 | AP | 1982/06/28 | Manufacturing Change or Addition | | 050368 | 039 | AP | 1981/12/23 | Control Supplement | | 050368 | 038 | AP | 1981/02/11 | Control Supplement | | 050368 | 037 | AP | 1981/03/24 | Labeling Revision | | 050368 | 036 | AP | 1981/01/22 | Labeling Revision | | 050368 | 035 | AP | 1980/10/21 | Labeling Revision | | 050368 | 034 | AP | 1980/02/06 | Control Supplement | | 050368 | 033 | AP | 1980/01/31 | Control Supplement | | 050368 | 032 | AP | 1979/02/14 | Control Supplement | | 050368 | 031 | AP | 1978/03/06 | Control Supplement | | 050368 | 030 | AP | 1977/01/21 | Control Supplement | | 050368 | 029 | AP | 1976/03/26 | Labeling Revision | | 050368 | 028 | AP | 1976/03/26 | Labeling Revision | | 050368 | 027 | AP | 1976/01/29 | Control Supplement | | 050368 | 026 | AP | 1975/09/09 | Labeling Revision | | 050368 | 025 | AP | 1975/01/28 | Control Supplement | | 050368 | 024 | AP | 1974/07/23 | Labeling Revision | | 050368 | 023 | AP | 1973/11/12 | Control Supplement | | 050368 | 022 | AP | 1973/02/16 | Control Supplement | | 050368 | 021 | AP | 1972/11/22 | Control Supplement | | 050368 | 020 | AP | 1972/10/31 | Labeling Revision | | 050368 | 019 | AP | 1972/11/03 | Labeling Revision | | 050368 | 018 | AP | 1971/12/01 | Control Supplement | | 050368 | 017 | AP | 1970/12/15 | Control Supplement | | 050368 | 016 | AP | 1969/12/15 | Control Supplement | | 050368 | 015 | AP | 1969/05/09 | Labeling Revision | | 050368 | 014 | AP | 1969/04/28 | Manufacturing Change or Addition | | 050368 | 013 | AP | 1969/02/11 | Manufacturing Change or Addition | | 050368 | 012 | AP | 1969/01/16 | Control Supplement | | 050368 | 011 | AP | 1967/05/17 | Labeling Revision | | 050368 | 010 | AP | 1993/07/14 | Labeling Revision | | 050368 | 009 | AP | 1993/07/14 | Labeling Revision | | 050368 | 008 | AP | 1987/05/22 | Labeling Revision | | 050368 | 007 | AP | 1967/05/03 | New Dosage Regimen | | 050368 | 006 | AP | 1986/04/15 | Formulation Revision | | 050368 | 005 | AP | 1986/03/10 | Labeling Revision | | 050368 | 004 | AP | 1966/01/14 | Expiration Date Change | | 050368 | 003 | AP | 1985/03/27 | Control Supplement | | 050368 | 002 | AP | 1984/03/06 | Package Change | | 050368 | 001 | AP | 1982/12/28 | Control Supplement | | 050368 | 000 | AP | 1964/06/29 | Approval |
|